The post-treatment minimal residual disease (MRD) profiles of glioblastoma patients were mapped using single cell sequencing to find a genetic signature that predicted how the cancer would recur in each individual.
CAHS fellows are elected by their peers in recognition of excellence in academic health sciences and their lifelong commitment to their fields.
Fewer families have sought in-person exams during the pandemic, sometimes delaying a diagnosis or treatment. For some children with brain cancer, this can have devastating consequences.